none6noneA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. MeriggiolaA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. Meriggiol
CONTEXT: The impact of gender-affirming hormone therapy (HT) on cardiometabolic parameters is largel...
none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...
none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...
none10noneM.C. Meriggiola; F. Armillotta; A. Costantino; P. Altieri; F. Saad; T.F. Kalhorn; A.M. Per...
none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...
none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...
none4noneF. Armillotta; M.C. Meriggiola; L. D'Emidio; G. Pelusi.F. Armillotta; M.C. Meriggiola; L. D...
none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...
none10noneA.M. Perrone; F. Armillotta; G. Formelli; P. Casadio; N.C.M. Salfi; L. Badiali De Giorgi; ...
Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (F...
none7noneM.C. Meriggiola; A. Costantino; F. Armillotta; M. Berra; G. Pelusi; S. Cerpolini; L. D'Emid...
none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...
Context: The impact of gender-affirming hormone therapy (HT) on cardiometabolic parameters is largel...
CONTEXT: The impact of gender-affirming hormone therapy (HT) on cardiometabolic parameters is largel...
none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...
none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...
none10noneM.C. Meriggiola; F. Armillotta; A. Costantino; P. Altieri; F. Saad; T.F. Kalhorn; A.M. Per...
none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...
none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...
none4noneF. Armillotta; M.C. Meriggiola; L. D'Emidio; G. Pelusi.F. Armillotta; M.C. Meriggiola; L. D...
none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...
none10noneA.M. Perrone; F. Armillotta; G. Formelli; P. Casadio; N.C.M. Salfi; L. Badiali De Giorgi; ...
Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (F...
none7noneM.C. Meriggiola; A. Costantino; F. Armillotta; M. Berra; G. Pelusi; S. Cerpolini; L. D'Emid...
none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...
Context: The impact of gender-affirming hormone therapy (HT) on cardiometabolic parameters is largel...
CONTEXT: The impact of gender-affirming hormone therapy (HT) on cardiometabolic parameters is largel...
none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...